2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Medical Seminar

[MeS09] Medical Seminar 9　Treatment options for relapsed and refractory multiple myeloma after lenalidomide-containing therapy

Thu. Feb 17, 2022 12:15 PM - 1:05 PM Room 11 and 12 (Prince Hall 1 and 2, B2F, The Prince Kyoto Takaragaike)

Chair：Shigeki Ito（Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine）

Sponsored by Bristol Myers Squibb K.K.

[MeS09-1] Treatment options for relapsed and refractory multiple myeloma after lenalidomide-containing therapy

○Shinsuke Iida (Department of Hematology and Oncology, Nagoya City University Hospital)